Pathological factors associated with omental metastases in endometrial cancer

Purpose of investigation: This study aimed to assess the role of omentectomy in the surgical therapy of endometrial cancer. Materials and Methods: A retrospective study was performed in 98 patients who were pathologically diagnosed with endometrial cancer and had initially undergone surgical therapy at the present institution. This study analyzed the relationship between omental metastasis and clinicopathological factors. Results: Omental metastasis was detected in nine patients (9%). On univariate analysis, significant number of omental metastatic lesions were detected in few cases by positive peritoneal cytology, adnexal metastasis, gross dissemination, and lymphovascular space involvement. On multivariate analysis, adnexal metastasis were a significant risk factor. The sensitivity of the special histological type and the specificity of the macroscopic peritoneal dissemination and adnexal metastasis were all high. Conclusion: Omentectomy plays a significant role in determining the exact surgical staging in cases with non-endometrioid cancer, adnexal metastasis, and macroscopic peritoneal dissemination.

Endometrial cancer; Omentectomy; Omental metastasis; Pathological factor; Uterine cancer.

[1] Lurain J.R.: “Uterine Cancer”. In: Berek J.S.: Berek & Novak’s Gynecology. 14th ed. Philadelphia: Williams & Wilkins, 2007, 1343.

[2] Creasman W.T., Morrow C.P., Bundy B.N., Homesley H.D., Graham J.E., Heller P.B.: “Surgical pathologic spread patterns of endometrial cancer”. Cancer, 1987, 60, 2035.

[3] Abeler V.M., Kjorstad K.E.: “Endometrial adenocarcinoma in Norway: a study of a total population”. Cancer, 1991, 67, 3093.

[4] Sakuragi N., Hareyama H., Todo Y., Yamada H., Yamamoto R., Fujino T., et al.: “Prognostic significance of serous and clear cell adenocarcinoma in surgically staged endometrial carcinoma”. Acta Obstet. Gynecol. Scand., 2000, 79, 311.

[5] Hendrickson M., Ross J., Eifel P., Martinez A., Kempson R.: “Uterine Papillary serous carcinoma: A highly malignant form of endometrial adenocarcinoma”. Am. J. Surg. Pathol., 1982, 6, 93.

[6] Hanson M.B., van Nagell J.R. Jr., Powell D.E., Donaldson E.S., Gallion H., Merhige M., Pavlik E.J.: “The prognostic significance of lymphvascular space invasion in stage I endometrial cancer”. Cancer, 1985, 55, 1753.

[7] Morrow C.P., Bundy B.N., Kurman R.J., Creasman W.T., Heller P., Homesley H.D., Graham J.E.: “Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study”. Gynecol. Oncol., 1991, 40, 55.

[8] DiSaia P.J., Creasman W.T., Boronow R.C., Blessing J.A.: “Risk factors and recurrent patterns in stage I endometrial cancer”. Am. J. Obstet. Gynecol., 1985, 15, 1009.

[9] Greer E., Koh W.J., Abu-Rustum N.R., Apte S.M., Campos S.M., Chan J. et al.: “NCCN Practice Guidelines in Oncology Version 3. 2012 Uterine neoplasms”. Available at: http://www.tri-kobe.org/nccn/guideline/gynecological/english/uterine.pdf

[10] Fujiwara H., Saga Y., Takahashi K., Ohwada M., Enomoto A., Konno R., et al.: “Omental metastasis in clinical stage I endometrioid adenocarcinoma”. Int. J. Gynecol. Cancer, 2008, 18, 165.

[11] Metindir J., Dilek G.B.: “The role of omentectomy during the surgical staging in patients with clinical stage I endometrioid adenocarcinoma”. J. Cancer Res. Clin. Oncol., 2008, 134, 1067.

[12] Dilek S., Dilek U., Dede M., Deveci M.S., Yenen M.C.: “The role of omentectomy and appendectomy during the surgical staging of clinical stage I endometrial cancer”. Int. J. Gynecol. Cancer, 2006, 16, 795.

[13] Chen S.S., Spiegel G.: “Stage I endometrial carcinoma. Role of omental biopsy and omentectomy”. J. Reprod. Med., 1991, 36, 627.

[14] Eto T., Saito T., Kasamatsu T., Nakanishi T., Yokota H., Satoh T., et al.: “Clinicopathological prognostic factors and the role of cytoreduction in surgical stage IVb endometrial cancer: A retrospective multi-institutional analysis of 248 patients in Japan”. Gynecol. Oncol., 2012, 127, 338.

[15] Slomovitz B.M., Burke T.W., Eifel P.J., Ramondetta L.M., Silva E.G., Jhingran A., et al.: “Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases”. Gynecol. Oncol., 2003, 91, 463.